Clinical Trial Update: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose [Phase 3]

View source ↗

Summary

Pfizer is conducting a Phase 3 trial to evaluate revaccination in subsequent pregnancies using a bivalent RSV vaccine and to determine how long protection lasts…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• ABRYSVO

Snippet

Sponsor: Pfizer | Conditions: RSV Infection | Phase 3 | Status: RECRUITING